Industry reports
Editor highlights

Publication dates

data types

Carcinoma Market and Forecasts, April 2014

You might be interested in: cancer, breast cancer, clinical trial, more »

1-10 of about 200 reports for Carcinoma

Cervical Cancer Sector Overview (cervical cancer, carcinoma)

  • Industry report
  • July 2012
  • 23 pages

... Lesions Squamous carcinoma: 95% association Hsil/cin ii, iii: 75 -95% Lsil/cini: 60% Ascus: 30% Adenocarcinoma: 12-30% association (ref: cuzick et al, 1992; schiffman et al, 1993; iarc, 1995 ...

Pharmaceutical Market Overview

  • Industry report
  • September 2013
  • 42 pages

... Prostate carcinoma natural history of prca hg pin latent prca localised prca metastatic prca (bone) normal death (transition zone) peripheral zone urethra where does one develop prca 85% Incidence of pr ...

Cancer Sector in The United States

  • Industry report
  • August 2013
  • 28 pages

... Simplified language for patients with lower literacy levels 11 11 click icon to add picture 17/08/2013 patient #10-9803 globular carcinoma arrow is pointing to cancerous mass 12 12 click icon to add ...

Pharmaceutical Market Analysis in Europe

  • Industry report
  • January 2013
  • 67 pages

... Platform in place to produce high quality colon carcinoma antibodies. A novel colon carcinoma selective antibody has been obtained and is currently being 44 vald. Cosmo has demonstrated that oral ...

Pharmaceutical Sector Analysis in Europe

  • Industry report
  • January 2013
  • 67 pages

... Monoclonal antibody obtained from a cancer patient. Simultaneously, aimm is generating antibodies against carcino embryogenic antigen (cea), which is expressed by >90% of colon carcinomas and therefore ...

Colorectal Cancer Market in The United States

  • Industry report
  • September 2012
  • 26 pages

... Goede: cost savings to medicare with crc screening in pre-medicare population adenoma to carcinoma pathway normal epithelium colorectal cancer small adenoma ...

Pharmaceutical Production and Trade Statistics

  • Industry report
  • April 2012
  • 15 pages

... An indica- tion of the value of this test in individual cases is that abnormally reduced values were found in 15 of the 17 cases of carcinoma and 12 of the 15 cases of chronic pancreatitis. In nine of the 14 ...

The Malaysian Cancer Sector Brief

  • Industry report
  • June 2012
  • 6 pages

... Micromol/l in the control group (table 2). Sera levels of advanced oxidation protein products rose to 0.918 Micromol/l in the frank oral squamous cell carcinoma group as against a minimum of 0 ...

Pharmaceutical in Italy : Innovation and Technology Trends

  • Industry report
  • January 2012
  • 14 pages

... Breast carcinoma ain457 arthritides (ra, as, pa)6 bym338 sibm15 lci699 cushing s disease acz885secondary prevention of cardiovascular events fingolimod cidp16 ati355 spinal cord lesions auy922 solid ...

Cancer in The United States : Innovation and Technology Trends

  • Industry report
  • May 2013
  • 17 pages

... To overcome obstacles to achieving long-term goals what properties of non-malignant lesions (in situ ca S) predict the likelihood of invasive disease Ductal carcinoma in situ (dcis) pancreatic ...

» Purchase Premium Reports (From $ 250 - $ 6 650)

65 reports for Carcinoma
Sunshine Biopharma, Inc. (Symbol:SBFM) SWOT Analysis, Strategy, Revenues and Profits

Sunshine Biopharma, Inc. (Symbol:SBFM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • April 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

» Read our Company Profiles

1 Companies for Carcinoma

Roche Holding AG


ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.